Harry Alcorn, Jr.
2020
In 2020, Harry Alcorn, Jr. earned a total compensation of $509.1K as Senior Vice President of Clinical Operations at DiaMedica Therapeutics, a 35% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $83,662 |
|---|---|
| Option Awards | $119,140 |
| Salary | $291,413 |
| Other | $14,850 |
| Total | $509,065 |
Alcorn received $291.4K in salary, accounting for 57% of the total pay in 2020.
Alcorn also received $83.7K in non-equity incentive plan, $119.1K in option awards and $14.9K in other compensation.
Rankings
In 2020, Harry Alcorn, Jr.'s compensation ranked 10,982nd out of 13,090 executives tracked by ExecPay. In other words, Alcorn earned more than 16.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,982 out of 13,090 | 16th |
Division Manufacturing | 4,688 out of 5,621 | 17th |
Major group Chemicals And Allied Products | 1,947 out of 2,254 | 14th |
Industry group Drugs | 1,704 out of 1,954 | 13th |
Industry Pharmaceutical Preparations | 1,259 out of 1,459 | 14th |
Source: SEC filing on April 5, 2022.
Alcorn's colleagues
We found two more compensation records of executives who worked with Harry Alcorn, Jr. at DiaMedica Therapeutics in 2020.